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In Bangladesh, serological tests have been widely used for the primary screening of visceral leishmaniasis (VL). Several serologic
tests are available for the diagnosis of VL. Selection of the best test is important to permit diagnostic diﬀerentiation between
symptomatic and asymptomatic patients and to reduce cross-reactivity. We evaluated the eﬀectiveness of a new serological test
“Onsite Leishmania Ab Rapid Test” as a part of “quality assurance” activities for the kala azar elimination programme of the
Government of Bangladesh. Plasma samples of 100 parasitologically conﬁrmed cases of VL along with 101 healthy controls were
tested, and “Onsite Leishmania Ab Rapid Test” strip tests were positive in 94 out of 100 conﬁrmed VL cases, whereas four out
of 51 healthy subjects from the VL endemic areas also tested positive. All the 50 healthy volunteers tested negative. Thus, the
sensitivity and speciﬁcity of “Onsite Leishmania Ab Rapid Test” strip test were found to be 94% (95% CI: 87–98) and 96% (95%
CI: 90–99), respectively. This study showed that the performance of the “Onsite Leishmania Ab Rapid Test” strip tests was up to
the recommended level.
1.Introduction
Kala azar or visceral leishmaniasis (VL) is a vector-borne
parasitic disease endemic in 45 of 64 districts of Bangladesh
where 65 million people have been estimated to be at
risk of contracting the disease [1]. The disease presents
with prolonged fever, anemia, splenomegaly, anorexia, and
wasting and is typically found among the rural poor of the
endemic countries. India, Bangladesh, and Nepal together
account for about 60% of all the new cases of kala azar which
is an estimated 500,000 every year [2]. The governments of
India, Bangladesh, and Nepal signed an agreement in 2005
to make joint eﬀorts to eliminate kala azar from this region.
The strategy for the elimination programme relies on three
main components: rapid diagnosis, eﬀective treatment, and
integrated vector control.
An immunochromatographic test based on a recombi-
nant 39-amino acid repeat antigen, conserved in the kinesin
region of Leishmania chagasi, known as rK-39 strip test
has been the most widely accepted rapid diagnostic test
for VL in South Asia [3, 4]. The WHO has recommended
rK39 test as rapid diagnostic test (RDT) for VL in South
Asia. The Government of Bangladesh (GoB) procured a
new RDT kit with the brand name of “Onsite Leishmania
Ab Combo” (CTK Biotech Inc., San Diego, Calif, USA)
for the kala azar elimination programme through open
bidding as per existing policy. The aim of the study was to
evaluate the sensitivity and speciﬁcity of “Onsite Leishmania
Ab Rapid Test” strips to determine whether these kits
conformed to the standard set by the kala azar elimination
programme.2 Journal of Parasitology Research
Table 1: Sensitivity and speciﬁcity of “Onsite Leishmania Ab Rapid Test” strips for diagnosis of VL in Bangladesh.
Patients and healthy controls Onsite Leishmania Ab Rapid Test (RDT)∗χ
Total
Positive Negative
Kala azar conﬁrmed cases 94 6 100
Healthy control from endemic area 4 47 51
Healthy control from nonendemic area 0 50 50
∗Sensitivity = 94% (95% CI: 86.9–97.5); speciﬁcity = 96% (95% CI: 89.6–98.8); positive predictive value (PPV) = 95.9% (95% CI: 89.3–98.7); negative
predictive value (NPV) = 94.2% (95% CI: 87.2–97.6).
χSensitivity, speciﬁcity, PPV, NPV, and 95% CI of all were calculated by the Clinical Calculator One (http://faculty.vassar.edu/lowry/clin1.html).
2.MaterialsandMethods
We used plasma samples of 100 conﬁrmed cases of VL who
were randomly selected out of 200 patients enrolled into a
clinical trial to evaluate the safety and eﬃcacy of treatment
with sodium stibogluconate (SSG) in Bangladesh between
May 2007 and May 2009 (ClinicalTrials.gov, Identiﬁer:
NCT01240473). All of these patients resided in Mymensingh
and presented with a history of fever for two weeks or more
and tested positive for VL by parasitological examination of
theirsplenictissue.Wealsoenrolled51healthycontrolsfrom
the same endemic region of Mymensingh and 50 healthy
controls from Mirpur of Dhaka City, a nonendemic area
for VL. Healthy volunteers were selected from individuals
who did not have a past history of VL. All subjects who
participated in the study gave their informed consent before
joining the study. The original identiﬁcation labels of the
samples were stripped oﬀ before performing the test. The
technician who performed the test was completely blind
about the cases and the healthy volunteers.
The VL and healthy volunteer samples used in this study
were collected from SSG evaluation study approved by the
institutionalEthicalReviewCommitteeandResearchReview
Committee of the International Centre for Diarrhoeal Dis-
ease Research, Bangladesh (ICDDR,B) where further use of
the samples was consented from the participants.
Blood from VL patients and healthy volunteers was
collectedinaEDTA-containingtubeandthencentrifugedfor
separation of plasma at the ﬁeld laboratory in Mymensingh
where the “Onsite Leishmania Ab Rapid Test” strip test was
performed according to manufacturer’s instruction. Brieﬂy,
5μL of plasma samples was applied to the base of nitro-
cellulose strips impregnated with recombinant leishmanial
antigen, then 2-3 drops of the supplied sample diluent buﬀer
(phosphate-buﬀered saline, plus bovine serum albumin)
were added, and the strip was placed ﬂat. The appearance
of a lower red band (Control band) indicated the proper
functioning of the test while the appearance of an upper red
band (Test band) indicated the presence of antileishmanial
antibody, signifying a positive test. Usually tests were read
within 15 minutes, but positive results could be visible as
short as 1 minute.
3. Results
Sensitivity and speciﬁcity were computed along with 95%
conﬁdence interval (CI) using the Epi Info software (version
6.02; CDC, Atlanta, Ga, USA). Data were also analyzed by
2 × 2 contingency tables using the SPSS software (version
10.0) for Windows (release 10.0.1, standard version, 1999;
SPSS Inc., Chicago, Ill, USA).
“Onsite Leishmania Ab Rapid Test” strip tests were
positive in 94 out of 100 conﬁrmed cases of VL, whereas 4
of 51 healthy subjects from the VL endemic areas were also
tested positive. None of the 50 healthy volunteers from the
nonendemic areas were positive with “Onsite Leishmania Ab
Rapid Test” strip test. Thus, the sensitivity and speciﬁcity
of “Onsite Leishmania Ab Rapid Test” strip test were found
to be 94% (95% CI: 86.9–97.5) and 96% (95% CI: 89.5–
98.7), respectively. Positive predictive value and negative
predictive value were found 95.9% (95% CI: 89.3–98.7) and
94.2% (95% CI: 87.2–97.6), respectively, (Table 1).
4. Discussion
Elimination of kala azar from Bangladesh and its neigh-
boring countries largely depends on strict adherence to
the regional strategic plan that strongly recommends the
use of rapid diagnostic tests for diagnosis of VL. The
commitment of the GoB to follow the national strategy for
elimination of VL is reﬂected by the present study which
was commissioned to ICDDR,B for quality assurance of the
diagnostic kits procured by the programme. According to
themanufacturer,“OnsiteLeishmaniaAbRapidTest”detects
antibodies against the same 39kD protein as reported by
the manufacturer of rK39 test (personal communication).
Although “Onsite Leishmania Ab Rapid Test” strips have
been commercially available worldwide, there is no report in
the current literature about its eﬃcacy in diagnosing active
cases of VL in South Asia. Multicentre studies on various
methods used for diagnosis of VL show wide variation in
their sensitivity and speciﬁcity depending on geographic
location [5]. It is, therefore, of great importance to do a
quality check before a new diagnostic kit is used by the
national programme. It has been recommended that an
ideal VL screening test for case detection should have a
sensitivity ≥ 95% and speciﬁcity ≥ 98% [6]. Serological
test performance often varies with geographical diﬀerences.
So multicentre studies need to be conducted to check the
performance of this “Onsite Leishmania Ab Rapid Test”
in diﬀerent geographic location. We are also curious to
see the performance of these new kits for the detection of
antileishmanial Ab in urine as urine-based rK39 has already
been evaluated recently [7]. This limited study showed thatJournal of Parasitology Research 3
the sensitivity of the “Onsite Leishmania Ab Rapid Test”
strips, also referred to as RDT for kala azar, procured by the
programme was considered to be up to the recommended
level. Samples from other diseases were not included in
the assessment of speciﬁcity, which is a limitation of this
study. This critical information on the quality of “Onsite
Leishmania Ab Rapid Test” test strip for diagnosis of kala
azar in Bangladesh helped the programme to take informed
decision before using the same diagnostic kit in the endemic
areas.
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